Home > Newsletters > Washington Drug Letter > Thirty-One States Call on SCOTUS to Quash Pay-for Delay Deals
Washington Drug Letter
Nov. 26, 2012 | Vol. 44 No. 47
Thirty-One States Call on SCOTUS to Quash Pay-for Delay Deals
Attorneys general from 31 states have joined the FTC in urging the Supreme Court to review the legality of — and halt — generic and brand-drug makers’ pay-for-delay agreements by overturning an 11th Circuit Court’s decision that upheld the legality of reverse patent settlements.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.